Deadlines
Letter of Intent: May 1, 2024
Invitation to Submit Application: July 1, 2024
Full Application Deadline: August 29, 2024
Award Amount: $30,000 a year for up to 2 years
Description
The PhRMA Foundation’s Translational Medicine Program focuses specifically on novel research that uses the “bedside to bench” approach to address unmet needs in the diagnosis, treatment, and prevention of disease. The Foundation seeks research proposals that focus on identifying unmet clinical needs and developing new diagnostic, experimental, and computational approaches and technologies to improve patient care and management.
Applicants are encouraged to work with clinical collaborators to identify unmet clinical needs. Plans to corroborate results from model systems need to include methods to validate findings in human samples, subjects, or patients and be documented in the proposal.
Proposals should integrate innovative technologies, with advanced biological, chemical, diagnostic, and pharmacological sciences and engineering methodologies in areas that include but not are limited to:
- Genetics and Epigenetics (Molecular, Pharmaco-, Population, Medical)
- Omics (Functional, Structural, Toxico-, Pharmaco-, Comparative)
- Systems (Biology and Pharmacology)
- Pathways and Networks
- Integrative Biology
- Modeling and Simulation
- Target Identification and Validation
- Biomarker Identification and Validation
- Molecular Epidemiology
- Imaging
- Disease Modeling
For more information, please see the opportunity webpage.